Angiotensin-converting enzyme - new insights into structure, biological significance and prospects for domain-selective inhibitors.
| dc.contributor.author | Watermeyer, Jean M | |
| dc.contributor.author | Kröger, Wendy L | |
| dc.contributor.author | Sturrock, Edward D | |
| dc.contributor.author | Ehlers, Mario R W | |
| dc.date.accessioned | 2016-07-28T13:41:13Z | |
| dc.date.available | 2016-07-28T13:41:13Z | |
| dc.date.issued | 2009 | |
| dc.date.updated | 2016-07-28T13:39:38Z | |
| dc.description.abstract | Somatic angiotensin-converting enzyme (ACE) - well known for its role in cardiovascular pathophysiology - has an unusual, two-domain, double active-site structure. The two domains (designated N and C) are 55% identical and each contains a similar active site with overlapping but distinct substrate preferences. While both convert angiotensin I to angiotensin II in vitro, current evidence suggests the C domain site predominates in this role in vivo. The N domain site inactivates a hemoregulatory and antifibrotic peptide, AcSDKP, in vivo, although the significance of this remains unclear. However, differences in the characteristics of the two domains may result in different context-dependent activities, as is the case with other enzymes containing tandem repeats. The N domain may also have a role in modulating C domain activity, through a combination of inter-domain cooperativity and structural stabilization. Comparison of ACE with its structural homologues reveals conservation of peptidase activity and a tendency to hinge about the active-site cleft. Recent work on ACE active-site mutants containing one or more key residues replaced by their cognate residues from the other domain, synthesis of domain-selective inhibitors, and co-crystal structures of each domain with such inhibitors, has led to a better resolution of the basis for domain selectivity and should enable the design of next-generation, domain-selective inhibitors with distinct pharmacological profiles. | en_ZA |
| dc.identifier.apacitation | Watermeyer, J. M., Kröger, W. L., Sturrock, E. D., & Ehlers, M. R. W. (2009). Angiotensin-converting enzyme - new insights into structure, biological significance and prospects for domain-selective inhibitors. <i>Current Enzyme Inhibition</i>, http://hdl.handle.net/11427/21003 | en_ZA |
| dc.identifier.chicagocitation | Watermeyer, Jean M, Wendy L Kröger, Edward D Sturrock, and Mario R W Ehlers "Angiotensin-converting enzyme - new insights into structure, biological significance and prospects for domain-selective inhibitors." <i>Current Enzyme Inhibition</i> (2009) http://hdl.handle.net/11427/21003 | en_ZA |
| dc.identifier.citation | Watermeyer, J. M., Kroger, W. L., Sturrock, E. D., & Ehlers, M. R. (2009). Angiotensin-converting enzyme-New insights into structure, biological significance and prospects for domain-selective inhibitors. Current Enzyme Inhibition, 5(3), 134-147. | en_ZA |
| dc.identifier.issn | 1573-4080 | en_ZA |
| dc.identifier.ris | TY - Journal Article AU - Watermeyer, Jean M AU - Kröger, Wendy L AU - Sturrock, Edward D AU - Ehlers, Mario R W AB - Somatic angiotensin-converting enzyme (ACE) - well known for its role in cardiovascular pathophysiology - has an unusual, two-domain, double active-site structure. The two domains (designated N and C) are 55% identical and each contains a similar active site with overlapping but distinct substrate preferences. While both convert angiotensin I to angiotensin II in vitro, current evidence suggests the C domain site predominates in this role in vivo. The N domain site inactivates a hemoregulatory and antifibrotic peptide, AcSDKP, in vivo, although the significance of this remains unclear. However, differences in the characteristics of the two domains may result in different context-dependent activities, as is the case with other enzymes containing tandem repeats. The N domain may also have a role in modulating C domain activity, through a combination of inter-domain cooperativity and structural stabilization. Comparison of ACE with its structural homologues reveals conservation of peptidase activity and a tendency to hinge about the active-site cleft. Recent work on ACE active-site mutants containing one or more key residues replaced by their cognate residues from the other domain, synthesis of domain-selective inhibitors, and co-crystal structures of each domain with such inhibitors, has led to a better resolution of the basis for domain selectivity and should enable the design of next-generation, domain-selective inhibitors with distinct pharmacological profiles. DA - 2009 DB - OpenUCT DP - University of Cape Town J1 - Current Enzyme Inhibition LK - https://open.uct.ac.za PB - University of Cape Town PY - 2009 SM - 1573-4080 T1 - Angiotensin-converting enzyme - new insights into structure, biological significance and prospects for domain-selective inhibitors TI - Angiotensin-converting enzyme - new insights into structure, biological significance and prospects for domain-selective inhibitors UR - http://hdl.handle.net/11427/21003 ER - | en_ZA |
| dc.identifier.uri | http://hdl.handle.net/11427/21003 | |
| dc.identifier.uri | http://www.ingentaconnect.com/content/ben/cei/2009/00000005/00000003/art00002 | |
| dc.identifier.vancouvercitation | Watermeyer JM, Kröger WL, Sturrock ED, Ehlers MRW. Angiotensin-converting enzyme - new insights into structure, biological significance and prospects for domain-selective inhibitors. Current Enzyme Inhibition. 2009; http://hdl.handle.net/11427/21003. | en_ZA |
| dc.language | eng | en_ZA |
| dc.publisher | Bentham Science Publishers | en_ZA |
| dc.publisher.institution | University of Cape Town | |
| dc.source | Current Enzyme Inhibition | en_ZA |
| dc.source.uri | http://www.ingentaconnect.com/content/ben/cei/2009/00000005/00000003/art00002 | |
| dc.subject.other | AcSDKP | |
| dc.subject.other | Angiotensin-converting enzyme (ACE) | |
| dc.subject.other | crystal | |
| dc.subject.other | domain-selective inhibitors | |
| dc.subject.other | metallopeptidase | |
| dc.title | Angiotensin-converting enzyme - new insights into structure, biological significance and prospects for domain-selective inhibitors. | en_ZA |
| dc.type | Journal Article | en_ZA |
| uct.type.filetype | Text | |
| uct.type.filetype | Image | |
| uct.type.publication | Research | en_ZA |
| uct.type.resource | Article | en_ZA |
Files
License bundle
1 - 1 of 1
Loading...
- Name:
- license.txt
- Size:
- 1.72 KB
- Format:
- Item-specific license agreed upon to submission
- Description: